AlzChem Group AG | Finanzwire

Basculer en Français

8301	Companies
115073	Keywords
55422	Articles
62513	Press releases

Home
Companies
AlzChem Group AG

BRIEF

published on 05/07/2024 at 16:26, 6 months 14 days ago

AlzChem Group AG Gains Strong Shareholder Support and Increases Dividend

Corporate Governance Dividend Increase Alzchem Group AG Shareholder Meeting 2023 Financial Performance
PRESS RELEASE

published on 05/07/2024 at 16:21, 6 months 14 days ago

Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved. Shareholders back company direction and approve higher dividend amid strong earnings performance

Annual General Meeting Shareholders Dividend Increase Alzchem Group AG Earnings Performance
BRIEF

published on 04/30/2024 at 07:05, 6 months 21 days ago

AlzChem Group AG Reports Solid First Quarter in 2024

Alzchem Group AG EBITDA Growth Specialty Chemicals Financial Performance 2024 Q1 Business Report
PRESS RELEASE

published on 04/30/2024 at 07:00, 6 months 21 days ago

Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
Alzchem Group AG reports 31.7% EBITDA growth in Q1 2024, with strong performance in Specialty Chemicals business. Forecasts for full year 2024 confirmed

Financial Performance Forecasts Alzchem Group AG EBITDA Growth Specialty Chemicals
BRIEF

published on 03/15/2024 at 18:01, 8 months 6 days ago

AlzChem Group AG Secures EUR 34.4 Million from EU for Expansion

Production Expansion Defense Technology Alzchem Group AG EU Funding ASAP Funding
PRESS RELEASE

published on 03/15/2024 at 17:56, 8 months 6 days ago

EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
Alzchem Group AG receives EUR 34.4 million in EU funding for capacity expansion of nitroguanidine production and modernization of guanidine nitrate facilities

Alzchem Group AG EU Funding Investment Grant Nitroguanidine Production Guanidine Nitrate
BRIEF

published on 03/11/2024 at 11:20, 8 months 10 days ago

Crearene AG and Alzchem Group AG Report Success in Creatine Dialysis Treatment Study

Clinical Study Patient Safety Alzchem Group AG Creatine Dialysis Treatment Crearene AG
PRESS RELEASE

published on 03/11/2024 at 11:15, 8 months 10 days ago

Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Alzchem Group AG and Crearene AG achieve successful addition of creatine to dialysis patient treatments, demonstrating technical feasibility and patient safety. Collaboration extended for medical applications

Alzchem Group AG Crearene AG Creatine Dialysis Treatments Medical Applications
BRIEF

published on 03/01/2024 at 07:05, 8 months 20 days ago

Alzchem Group AG Reports Significant EBITDA Growth and Optimistic 2024 Forecast

Dividend Increase 2024 Forecast Alzchem Group AG EBITDA Growth Specialty Chemicals
PRESS RELEASE

published on 03/01/2024 at 07:00, 8 months 20 days ago

Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
Alzchem Group AG reports a 32.4% increase in EBITDA to EUR 81.4 million in 2023, highlighting growth in specialty chemicals and plans for dividend increase

EBITDA Dividend Increase 2023 Financial Results Alzchem Group AG Specialty Chemicals

Accesswire

Published on 11/21/2024 at 17:35, 1 hour 10 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 1 hour 15 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 2 hours 15 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 44 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 45 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 18:36, 9 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 47 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 54 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 54 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 16:00, 2 hours 45 minutes ago

Director/PDMR Shareholding

Les Echos

Published on 11/21/2024 at 06:58, 11 hours 47 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 23 hours 25 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 1 hour ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 1 hour ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 11 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE